Provided by Tiger Trade Technology Pte. Ltd.

Agree

73.88
-0.5700-0.77%
Pre-market: 73.990.1100+0.15%07:02 EDT
Volume:734.76K
Turnover:54.32M
Market Cap:9.19B
PE:39.90
High:74.60
Open:74.60
Low:73.72
Close:74.45
52wk High:82.08
52wk Low:69.56
Shares:124.38M
Float Shares:122.18M
Volume Ratio:0.28
T/O Rate:0.60%
Dividend:3.14
Dividend Rate:4.25%
EPS(TTM):1.85
EPS(LYR):1.77
ROE:3.70%
ROA:2.40%
PB:1.45
PE(LYR):41.74

Loading ...

Greenvale, Patronus Agree to Amend Timetable for Northern Territory Project Uranium Rights Acquisition; Greenvale Shares Jump 8%

MT Newswires Live
·
9 hours ago

Agree Realty (ADC) Could Be 13% Undervalued On Its Monthly Dividend Update

Simply Wall St.
·
Yesterday

Hidropar Shareholders Agree $6.5 Million Control-Change Deal With New Investor

TIPRANKS
·
Aug 21

China, Switzerland Agree On Trade Deal Scrapping Most Tariffs

MT Newswires Live
·
Aug 21

CSTONE PHARMA-B Gets NMPA Green Light for CS5007 Investigational New Drug Application

Stock News
·
Aug 21

CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007

TIPRANKS
·
Aug 21

Kronox Promoters Agree to Sell Majority Stake to Indo Borax

TIPRANKS
·
Aug 20

Lepu Biopharma Delivers Revenue Growth as ADC Pipeline Advances

TIPRANKS
·
Aug 19

Agree Realty Declares Monthly Distribution of R$ 0.12 Per Unit, Payable Aug. 20

Reuters
·
Aug 18

Akari Therapeutics Reaffirmed Buy as Analyst Keeps $27 Price Target on Advancing Trop2 ADC and Strengthened PH1 Platform

TIPRANKS
·
Aug 17

Breakthrough: AstraZeneca and Daiichi Sankyo's ADC Shows Strong Efficacy in First-Line Lung Cancer Therapy

Stock News
·
Aug 17

ADC Therapeutics price target lowered to $5 from $10 at Guggenheim

TIPRANKS
·
Aug 17

ADC Therapeutics reports Q2 adjusted EPS (11c) vs. (25c) last year

TIPRANKS
·
Aug 17

Agree Realty (ADC) Earnings Call Highlights Growth, Discipline

TIPRANKS
·
Aug 15

ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says

MT Newswires Live
·
Aug 14

Boan Biotechnology Advances First-in-Class CD228 ADC With Positive Early Trial Data

TIPRANKS
·
Aug 14

Bioan Biotech's BA1302 (CD228 ADC) Completes China Phase Ia Clinical Study

Stock News
·
Aug 14

Innate Pharma launches €22.5m share placement to fund ADC pipeline and extend runway

TIPRANKS
·
Aug 14

Press Release: Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform

Dow Jones
·
Aug 14

Press Release: Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 14